Study Summary
This trial is testing whether taking saturation measurements at home has any real clinical benefit for patients with interstitial pulmonary diseases. Early results suggest that it may cause more anxiety and lead to more unnecessary doctor visits.
Eligible Conditions
- Interstitial Lung Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: 1 year
1 year
Acute exacerbation
Anxiety and depression score
Dyspnea score
Energy expenditure
Health care use (phone calls, medical consultation)
Mortality
Physical activity level
Pulmonary function decline
Quality of life by questionnaire
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control Group
1 of 2
Intervention Group
1 of 2
Active Control
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: Saturation at home · No Placebo Group · N/A
Intervention Group
Other
Experimental Group · 1 Intervention: Saturation at home · Intervention Types: OtherControl GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year
Who is running the clinical trial?
Fondation IUCPQOTHER
3 Previous Clinical Trials
190 Total Patients Enrolled
Laval UniversityLead Sponsor
391 Previous Clinical Trials
164,848 Total Patients Enrolled
Geneviève Dion, MDPrincipal InvestigatorInstitut universitaire de pneumologie et cardiologue de Québec - ULaval
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments